tyrosine kinase inhibitor IDRX-42

An orally bioavailable small molecule inhibitor of an as of yet undisclosed tyrosine kinase, with potential antineoplastic activity. Upon oral administration, tyrosine kinase inhibitor IDRX-42 inhibits the activity of an as of yet undisclosed tyrosine kinase. This may result in antitumor activity in tumor cells in which the tyrosine kinase is upregulated or dysregulated.